Tenpoint Therapeutics
Highly Engaged Employees
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
30 Broad St, Bourn, Cambridgeshire, CB23...Website
www.tenpointtherapeutics.comRevenue
<$5 MillionIndustry
About Tenpoint Therapeutics
Tenpoint Therapeutics Org Chart
Is Tenpoint Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Tenpoint Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Tenpoint Therapeutics has new funding data
Click to see if Tenpoint Therapeutics had a recent Job posting/layoffs
Check out if Tenpoint Therapeutics is spiking on competitors!
Product Launch: Get notified when Tenpoint Therapeutics launches new products
Check if Tenpoint Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Tenpoint Therapeutics
Tenpoint Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Tenpoint Therapeutics
Compare insights from companies similar to Tenpoint Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Tenpoint Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tenpoint Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tenpoint Therapeutics.
Tenpoint Therapeutics financials insights
Gather financial insights about Tenpoint Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$70M
Tenpoint Therapeutics Tech Stack
A closer look at the technologies used by Tenpoint Therapeutics
Most Recent Scoops
Tenpoint Therapeutics News & Media
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop
Ritedose partners with Tenpoint Therapeutics to manufacture YUVEZZI™, the first FDA-approved dual-action eye drop for presbyopia.Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial Officer
Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial Officer.Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
LONDON & SEATTLE--(BUSINESS WIRE)-- #ophthalmology--Tenpoint Therapeutics, Ltd. (“Tenpoint”), a global, clinical-stage biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that Henric Bjarke, Chief Executive Officer of Tenpoint Therapeutics, will participate in one-on-one meetings at the virtual Citi Biotech Private Access Day on April 24. About Tenpoint Therapeutics Tenpoint Therapeutics Ltd. is a global, clinical-stage bioTenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
LONDON & SEATTLE--(BUSINESS WIRE)-- #ophthalmology--Tenpoint Therapeutics Ltd. to Participate in the RBC Capital Markets Virtual Ophthalmology and 24th Annual Needham Virtual Healthcare Conferences
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tenpoint Therapeutics
Founded in 2020 and headquartered in Cambourne, United Kingdom, Tenpoint Therapeutics is a vision-restoring engineered cell-based therapeutics company. Tenpoint Therapeutics is embracing a new opportunity to fundamentally reshape the future for people with ocular diseases using vision-restoring engineered cell-based therapeutics & in vivo reprogram... Read More
